BPC-157 reversed corticosteroid-induced muscle damage in preclinical studies, restoring structure and function.- TB-500 showed potential in supporting cardiomyocyte survival and angiogenesis in ischemic models, with evidence of integrin-linked kinase (ILK) and Akt pathway involvement.- Early evidence suggests both compounds may support musculoskeletal healing and bone remodeling
BPC-157: nitric oxide, angiogenesis, tendon-fibroblast outgrowth BPC-157 (Body Protection Compound 157) is a 15-amino-acid pentadecapeptide first characterized by the Sikiric group at the University of Zagreb beginning in the early 1990s
Understanding peptide legal status in your area is essential before beginning any protocol
Your GLP-1 Standard Treatment Plan includes submission of your prescription to your desired local pharmacy (or Lilly Direct, NovoCare), as well as unlimited support from your healthcare provider and patient support team for your treatment duration (until your next follow-up is due)
(PubMed) Capelli I, Cianciolo G, Gasperoni L, et al